TY - JOUR T1 - Forecasting COVID-19 Spreading in Canada using Deep Learning JF - medRxiv DO - 10.1101/2021.05.01.21256447 SP - 2021.05.01.21256447 AU - Fadoua Khennou AU - Moulay A. Akhloufi Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/05/04/2021.05.01.21256447.abstract N2 - The novel coronavirus disease 2019 (COVID-19) is disrupting all aspects of our lives as the global spread of the virus continues. In this difficult period, various research projects are taking place to study and analyse the dynamics of the pandemic. In the present work, we firstly present a deep overview of the main forecasting models to predict the new cases of COVID-19. In this context, we focus on univariate time series models in order to analyze the dynamic change of this pandemic through time. We secondly shed light on multivariate time series forecasting models using weather and daily tests data, to study the impact of exogenous features on the progression of COVID-19. In the final stage of this paper, we present our proposed approach based on LSTM and GRU ensemble learning model and evaluate the results using the MAE, RMSE and MAPE for the prediction of new cases. The results of our experiments using the Canadian dataset show that the ensemble model performs well in comparison to other models. In addition, this research provides us with a new outcome regarding the dynamic correlation between temperature, humidity and daily test data and its impact on the new contaminated cases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by the Natural Sciences and Engineering Research Council of Canada (NSERC), Alliance Grants (ALLRP 552039-20), the New Brunswick Innovation Foundation (NBIF), COVID-19 Research Fund (COV2020-042), and the Atlantic Canada Opportunities Agency (ACOA), Regional Economic Growth through Innovation - Business Scale-Up and Productivity (project 217148).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB/oversight body approval or exemption was necessary as the data is publicly available.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used are available publicly as described in the dataset section. ER -